161 related articles for article (PubMed ID: 26620390)
1. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
3. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
4. Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.
La Rosa S; Uccella S; Dainese L; Marchet S; Placidi C; Vigetti D; Capella C
Endocr Pathol; 2008; 19(2):104-11. PubMed ID: 18568298
[TBL] [Abstract][Full Text] [Related]
5. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV
Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582
[TBL] [Abstract][Full Text] [Related]
6. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
[TBL] [Abstract][Full Text] [Related]
7. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery.
Dubois S; Guyétant S; Menei P; Rodien P; Illouz F; Vielle B; Rohmer V
Eur J Endocrinol; 2007 Aug; 157(2):141-7. PubMed ID: 17656591
[TBL] [Abstract][Full Text] [Related]
8. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptors in human pituitary tumors.
Burdman JA; Pauni M; Heredia Sereno GM; Bordón AE
Horm Metab Res; 2008 Aug; 40(8):524-7. PubMed ID: 18398784
[TBL] [Abstract][Full Text] [Related]
10. EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
Laitinen S; Martikainen PM; Tolonen T; Isola J; Tammela TL; Visakorpi T
Int J Cancer; 2008 Feb; 122(3):595-602. PubMed ID: 17943722
[TBL] [Abstract][Full Text] [Related]
11. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
[TBL] [Abstract][Full Text] [Related]
12. Survivin products in pituitary tumors.
Jankowska A; Wasko R; Waligorska-Stachura J; Andrusiewicz M; Jaskula M; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):1033-7. PubMed ID: 19112393
[TBL] [Abstract][Full Text] [Related]
13. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.
Fusco A; Zatelli MC; Bianchi A; Cimino V; Tilaro L; Veltri F; Angelini F; Lauriola L; Vellone V; Doglietto F; Ambrosio MR; Maira G; Giustina A; degli Uberti EC; Pontecorvi A; De Marinis L
J Clin Endocrinol Metab; 2008 Jul; 93(7):2746-50. PubMed ID: 18460561
[TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.
Mastronardi L; Guiducci A; Spera C; Puzzilli F; Liberati F; Ruggeri A; Peciarolo A
Tumori; 2000; 86(3):229-32. PubMed ID: 10939604
[TBL] [Abstract][Full Text] [Related]
16. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
[TBL] [Abstract][Full Text] [Related]
17. Recurrence in pituitary adenomas in childhood and adolescence.
Espay AJ; Azzarelli B; Williams LS; Bodensteiner JB
J Child Neurol; 2001 May; 16(5):364-7. PubMed ID: 11392522
[TBL] [Abstract][Full Text] [Related]
18. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
Johnson MD; Fan X; Bourne P; Walters D
J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
[TBL] [Abstract][Full Text] [Related]
20. Plurihormonality of pituitary adenomas in light of immunohistochemical studies.
Pawlikowski M; Kunert-Radek J; Radek M
Endokrynol Pol; 2010; 61(1):63-6. PubMed ID: 20205106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]